These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9548000)
1. Gene therapy for B cell lymphomas. Fielding AK; Russell SJ Cancer Surv; 1997; 30():327-42. PubMed ID: 9548000 [TBL] [Abstract][Full Text] [Related]
2. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Ruffini PA; Neelapu SS; Kwak LW; Biragyn A Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812 [TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
4. Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies. Leitch HA; Connors JM Curr Opin Investig Drugs; 2005 Jun; 6(6):597-604. PubMed ID: 15988911 [TBL] [Abstract][Full Text] [Related]
5. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777 [TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression. Huang H; Li F; Gordon JR; Xiang J Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic cancer vaccines. Acres B; Paul S; Haegel-Kronenberger H; Calmels B; Squiban P Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780 [TBL] [Abstract][Full Text] [Related]
8. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of hematological malignancies using dendritic cells. Van de Velde AL; Berneman ZN; Van Tendeloo VF Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells. Cui Y; Kelleher E; Straley E; Fuchs E; Gorski K; Levitsky H; Borrello I; Civin CI; Schoenberger SP; Cheng L; Pardoll DM; Whartenby KA Nat Med; 2003 Jul; 9(7):952-8. PubMed ID: 12778137 [TBL] [Abstract][Full Text] [Related]
13. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465 [TBL] [Abstract][Full Text] [Related]
14. Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cells. Cheadle EJ; Hawkins RE; Batha H; Rothwell DG; Ashton G; Gilham DE J Immunother; 2009 Apr; 32(3):207-18. PubMed ID: 19242379 [TBL] [Abstract][Full Text] [Related]